Gamal Esmat is a distinguished Professor at Endemic Medicine and Hepatogastroenterology Department, Cairo University.
He was Vice President of Cairo University for Graduate Studies and Research.
He published a vast number of scientific papers in top journa ls and was mainly concerned with hepatitis, hepatocellular carcinoma and liver transplantation.
Since 2001, he is the director of Clinical Research Unit, Hepatitis C Project, International Health Division, University of Maryland Baltimore.
He is a member of Numerous Scientific Societies and Organizations and per se was the president of IASL (International Association for the Study of the Liver) during the period 2006 – 2008 and is recently the WHO consultant for management of viral hepatitis.